Phase 1 study of anti-CD47 monoclonal antibody CC-90002 in patients with relapsed/refractory acute myeloid leukemia and high-risk myelodysplastic syndromes
2022 · Annals of Hematology · 84 citations
https://doi.org/10.1007/s00277-021-04734-2
X
Xin Wei
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
124
Papers
2.7K
Citations
26
h-index
64
i10-index
Xin Wei is an academic researcher from Sichuan University. The author has contributed to research in topics: Kidney Stones and Urolithiasis Treatments & Cancer Immunotherapy and Biomarkers & Multiple Myeloma Research and Treatments. The author has an h-index of 26, co-authored 106 publications.
ORCID: 0000-0001-9363-0455Papers by this author
worksLong noncoding RNA CYTOR in cancer: A TCGA data review
2018 · Clinica Chimica Acta · 43 citations
https://doi.org/10.1016/j.cca.2018.05.010
Suprapubic tube versus urethral catheter drainage after robot-assisted radical prostatectomy: a systematic review and meta-analysis
2018 · BMC Urology · 26 citations
https://doi.org/10.1186/s12894-017-0312-5
BET inhibitor trotabresib in heavily pretreated patients with solid tumors and diffuse large B-cell lymphomas
2023 · Nature Communications · 24 citations
https://doi.org/10.1038/s41467-023-36976-1
The association between hepatitis C virus infection and renal cell cancer, prostate cancer, and bladder cancer: a systematic review and meta-analysis
2021 · Scientific Reports · 15 citations
https://doi.org/10.1038/s41598-021-90404-2
Effect and safety of dual anti-human epidermal growth factor receptor 2 therapy compared to monotherapy in patients with human epidermal growth factor receptor 2-positive breast cancer: a systematic review
2014 · BMC Cancer · 7 citations
https://doi.org/10.1186/1471-2407-14-625
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat